These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 12795050)

  • 1. The role of COX-2 in breast and cervical cancer.
    Dannenberg AJ; Howe LR
    Prog Exp Tumor Res; 2003; 37():90-106. PubMed ID: 12795050
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclooxygenase-2 and skin carcinogenesis.
    Fürstenberger G; Marks F; Müller-Decker K
    Prog Exp Tumor Res; 2003; 37():72-89. PubMed ID: 12795049
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of cyclooxygenase-2 (COX-2) in breast cancer, and implications of COX-2 inhibition.
    Singh-Ranger G; Mokbel K
    Eur J Surg Oncol; 2002 Nov; 28(7):729-37. PubMed ID: 12431470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2: a target for the prevention and treatment of cancers of the upper digestive tract.
    Altorki NK; Subbaramaiah K; Dannenberg AJ
    Prog Exp Tumor Res; 2003; 37():107-23. PubMed ID: 12795051
    [No Abstract]   [Full Text] [Related]  

  • 5. The role of COX-1 and COX-2 in asthma pathogenesis and its significance in the use of selective inhibitors.
    Szczeklik A; Sanak M
    Clin Exp Allergy; 2002 Mar; 32(3):339-42. PubMed ID: 11940059
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacology and clinical action of COX-2 selective NSAIDs.
    Bovill JG
    Adv Exp Med Biol; 2003; 523():201-14. PubMed ID: 15088852
    [No Abstract]   [Full Text] [Related]  

  • 7. [COX-2 expression in gastric cancers].
    Sakamoto C
    Nihon Rinsho; 2001 Apr; 59 Suppl 4():598-603. PubMed ID: 11424449
    [No Abstract]   [Full Text] [Related]  

  • 8. COX-2 inhibitors: a review.
    Houston AM; Teach SJ
    Pediatr Emerg Care; 2004 Jun; 20(6):396-9; quiz 400-2. PubMed ID: 15179150
    [No Abstract]   [Full Text] [Related]  

  • 9. COX-1 and COX-2 products in the gut: therapeutic impact of COX-2 inhibitors.
    Whittle BJ
    Gut; 2000 Sep; 47(3):320-5. PubMed ID: 10940262
    [No Abstract]   [Full Text] [Related]  

  • 10. Cyclooxygenase-2: a target for the prevention and treatment of breast cancer.
    Howe LR; Subbaramaiah K; Brown AM; Dannenberg AJ
    Endocr Relat Cancer; 2001 Jun; 8(2):97-114. PubMed ID: 11397667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for cyclooxygenase-1 in neuropathic pain?
    Zeilhofer HU; Brune K
    Anesthesiology; 2003 Nov; 99(5):1043-4. PubMed ID: 14576535
    [No Abstract]   [Full Text] [Related]  

  • 12. COX-2 inhibitors and breast cancer.
    Singh Ranger G; Mokbel K
    ANZ J Surg; 2003 Aug; 73(8):565-6. PubMed ID: 12887516
    [No Abstract]   [Full Text] [Related]  

  • 13. The promise of coxibs: how far have we progressed?
    Schumacher HR
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S1-4. PubMed ID: 11992742
    [No Abstract]   [Full Text] [Related]  

  • 14. Cyclooxygenase-2 inhibitors in cancer prevention and treatment.
    Masferrer JL
    Adv Exp Med Biol; 2003; 532():209-13. PubMed ID: 12908559
    [No Abstract]   [Full Text] [Related]  

  • 15. Aspirin use and potential mechanisms for colorectal cancer prevention.
    Williams CS; Smalley W; DuBois RN
    J Clin Invest; 1997 Sep; 100(6):1325-9. PubMed ID: 9294096
    [No Abstract]   [Full Text] [Related]  

  • 16. Cyclooxygenase-2 and colorectal cancer.
    DuBois RN
    Prog Exp Tumor Res; 2003; 37():124-37. PubMed ID: 12795052
    [No Abstract]   [Full Text] [Related]  

  • 17. COX-2 inhibitors: background knowledge for clinical use. Summary.
    Katori M
    Inflamm Res; 1998 Oct; 47 Suppl 2():S117. PubMed ID: 9831334
    [No Abstract]   [Full Text] [Related]  

  • 18. The advent of highly selective inhibitors of cyclooxygenase--a review.
    Cryer B; Dubois A
    Prostaglandins Other Lipid Mediat; 1998 Aug; 56(5-6):341-61. PubMed ID: 9990677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclooxygenase-2 in lung cancer.
    Dubinett SM; Sharma S; Huang M; Dohadwala M; Pold M; Mao JT
    Prog Exp Tumor Res; 2003; 37():138-62. PubMed ID: 12795053
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemoprevention of breast cancer by targeting cyclooxygenase-2 and peroxisome proliferator-activated receptor-gamma (Review).
    Badawi AF; Badr MZ
    Int J Oncol; 2002 Jun; 20(6):1109-22. PubMed ID: 12011987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.